Chemotherapy for esophageal cancer

Esophageal cancer chemotherapy regimen is divided into two categories, neoadjuvant chemotherapy with 5-fluorouracil and its derivatives and cisplatin PF regimen, advanced tumor docetaxel or irinotecan can also be treated; targeted therapy such as nimotuzumab combination therapy to improve efficacy; immunotherapy such as PD-1 inhibitors, anrotinib anti-angiogenesis drugs can greatly improve the efficacy of advanced esophageal cancer. Chemotherapy has certain conditions. It is necessary to evaluate the patient's heart, liver, lung and kidney functions, biochemical indicators, functional status and symptom degree. It is necessary to fully evaluate the patient's liver and kidney functions, blood routine, ECG, complications and hearing loss problems of ears. PS score 0~1 is more ideal, and patients with 0~2 points should make appropriate dose adjustment. Chemotherapy is a kind of cytotoxic drugs, there will be some adverse reactions, but through the use of antiemetic drugs and comprehensive mitigation of adverse reactions, more than 90% of patients can tolerate.